The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. / Kiec-Wilk, B; Grzybowska-Galuszka, J; Polus, A; Pryjma, J; Knapp, A; Kristiansen, Karsten.

In: Journal of Physiology and Pharmacology, Vol. 61, No. 2, 2010, p. 217-25.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kiec-Wilk, B, Grzybowska-Galuszka, J, Polus, A, Pryjma, J, Knapp, A & Kristiansen, K 2010, 'The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC', Journal of Physiology and Pharmacology, vol. 61, no. 2, pp. 217-25. <http://www.jpp.krakow.pl/journal/archive/0410/pdf/217_0410_article.pdf>

APA

Kiec-Wilk, B., Grzybowska-Galuszka, J., Polus, A., Pryjma, J., Knapp, A., & Kristiansen, K. (2010). The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. Journal of Physiology and Pharmacology, 61(2), 217-25. http://www.jpp.krakow.pl/journal/archive/0410/pdf/217_0410_article.pdf

Vancouver

Kiec-Wilk B, Grzybowska-Galuszka J, Polus A, Pryjma J, Knapp A, Kristiansen K. The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. Journal of Physiology and Pharmacology. 2010;61(2):217-25.

Author

Kiec-Wilk, B ; Grzybowska-Galuszka, J ; Polus, A ; Pryjma, J ; Knapp, A ; Kristiansen, Karsten. / The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. In: Journal of Physiology and Pharmacology. 2010 ; Vol. 61, No. 2. pp. 217-25.

Bibtex

@article{64880e20a8fb11df928f000ea68e967b,
title = "The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC",
abstract = "The Jagged-Notch signalling, plays a crucial role in cell differentiation. Angiogenesis, is regulated by VEGF, bFGF as well as by the free fatty acid metabolites , which are regulators of transcription factors such as peroxisome proliferation activating receptors (PPARs). The study analyzed the signalling pathways involved in the regulation of Jagged-1/Notch-4 expression in endothelial cells (HUVECs) in response to VEGF, bFGF and PPAR-gamma exogenous activator - ciglitazone. HUVECs were incubated with investigated substances for 24 hours, with or without the presence of the MAP-kinases inhibitors were used. Jagged-1 and Notch-4 gene expression was determined using quantitative Real-Time PCR. The Jagged-1/Notch-4 protein expression was compared by flow cytometry, when the phosphorylation-dependent activation of kinases was estimated by Western-blot method. The opposite effect of VEGF, bFGF, or ciglitazone on the Jagged-1/Notch-4 expression on HUVEC was connected with the different activation of MAPKs. Ciglitazone, activated p38 MAPK pathway and simultaneously inhibited phosphorylation of p42/44 MAPK. The pro-angiogenic: bFGF and VEGF, also activated the p38 MAPK, but they did not attenuate the p42/44 MAPK phosphorylation. Maintaining of the Jagged/Notch interactions by VEGF, when down-regulation by bFGF and ciglitazone, seems to be dependent on the different effect on p38 MAPK and p42/44 MAPK pathway regulation.",
author = "B Kiec-Wilk and J Grzybowska-Galuszka and A Polus and J Pryjma and A Knapp and Karsten Kristiansen",
note = "Keywords: Blotting, Western; Calcium-Binding Proteins; Cells, Cultured; Fibroblast Growth Factor 2; Flow Cytometry; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Physiologic; PPAR gamma; Proto-Oncogene Proteins; Receptors, Notch; Signal Transduction; Thiazolidinediones; Umbilical Veins; Vascular Endothelial Growth Factor A; p38 Mitogen-Activated Protein Kinases",
year = "2010",
language = "English",
volume = "61",
pages = "217--25",
journal = "Journal of Physiology and Pharmacology",
issn = "0867-5910",
publisher = "Polskie Towarzystwo Fizjologiczne",
number = "2",

}

RIS

TY - JOUR

T1 - The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC

AU - Kiec-Wilk, B

AU - Grzybowska-Galuszka, J

AU - Polus, A

AU - Pryjma, J

AU - Knapp, A

AU - Kristiansen, Karsten

N1 - Keywords: Blotting, Western; Calcium-Binding Proteins; Cells, Cultured; Fibroblast Growth Factor 2; Flow Cytometry; Gene Expression Regulation; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Physiologic; PPAR gamma; Proto-Oncogene Proteins; Receptors, Notch; Signal Transduction; Thiazolidinediones; Umbilical Veins; Vascular Endothelial Growth Factor A; p38 Mitogen-Activated Protein Kinases

PY - 2010

Y1 - 2010

N2 - The Jagged-Notch signalling, plays a crucial role in cell differentiation. Angiogenesis, is regulated by VEGF, bFGF as well as by the free fatty acid metabolites , which are regulators of transcription factors such as peroxisome proliferation activating receptors (PPARs). The study analyzed the signalling pathways involved in the regulation of Jagged-1/Notch-4 expression in endothelial cells (HUVECs) in response to VEGF, bFGF and PPAR-gamma exogenous activator - ciglitazone. HUVECs were incubated with investigated substances for 24 hours, with or without the presence of the MAP-kinases inhibitors were used. Jagged-1 and Notch-4 gene expression was determined using quantitative Real-Time PCR. The Jagged-1/Notch-4 protein expression was compared by flow cytometry, when the phosphorylation-dependent activation of kinases was estimated by Western-blot method. The opposite effect of VEGF, bFGF, or ciglitazone on the Jagged-1/Notch-4 expression on HUVEC was connected with the different activation of MAPKs. Ciglitazone, activated p38 MAPK pathway and simultaneously inhibited phosphorylation of p42/44 MAPK. The pro-angiogenic: bFGF and VEGF, also activated the p38 MAPK, but they did not attenuate the p42/44 MAPK phosphorylation. Maintaining of the Jagged/Notch interactions by VEGF, when down-regulation by bFGF and ciglitazone, seems to be dependent on the different effect on p38 MAPK and p42/44 MAPK pathway regulation.

AB - The Jagged-Notch signalling, plays a crucial role in cell differentiation. Angiogenesis, is regulated by VEGF, bFGF as well as by the free fatty acid metabolites , which are regulators of transcription factors such as peroxisome proliferation activating receptors (PPARs). The study analyzed the signalling pathways involved in the regulation of Jagged-1/Notch-4 expression in endothelial cells (HUVECs) in response to VEGF, bFGF and PPAR-gamma exogenous activator - ciglitazone. HUVECs were incubated with investigated substances for 24 hours, with or without the presence of the MAP-kinases inhibitors were used. Jagged-1 and Notch-4 gene expression was determined using quantitative Real-Time PCR. The Jagged-1/Notch-4 protein expression was compared by flow cytometry, when the phosphorylation-dependent activation of kinases was estimated by Western-blot method. The opposite effect of VEGF, bFGF, or ciglitazone on the Jagged-1/Notch-4 expression on HUVEC was connected with the different activation of MAPKs. Ciglitazone, activated p38 MAPK pathway and simultaneously inhibited phosphorylation of p42/44 MAPK. The pro-angiogenic: bFGF and VEGF, also activated the p38 MAPK, but they did not attenuate the p42/44 MAPK phosphorylation. Maintaining of the Jagged/Notch interactions by VEGF, when down-regulation by bFGF and ciglitazone, seems to be dependent on the different effect on p38 MAPK and p42/44 MAPK pathway regulation.

M3 - Journal article

C2 - 20436223

VL - 61

SP - 217

EP - 225

JO - Journal of Physiology and Pharmacology

JF - Journal of Physiology and Pharmacology

SN - 0867-5910

IS - 2

ER -

ID: 21404996